Medical Lifting Slings Market Growth Factors, Trends and Forecast Report to 2024

San Francisco, 14 December 2018 – ‘’ Medical Lifting Sling Market Analysis By Product (Nylon, Padded, Mesh, Canvas), By Application (Transfer, Universal, Hammock, Standing, Seating, Toilet, Bariatric), By Usage (Reusable, Disposable) By End Use (Hospital, Home Healthcare, Elderly Care) And Segment Forecasts To 2024

The medical lifting sling market is expected to reach USD 1.1 billion by 2024, according to the new report by Grand View Research, Inc. Long term care is required in case of chronic disorders and surgical treatment. Medical lifting slings are essential elements in long term care and post operative recovery as they assist in patient transfer and other purposes. Increasing prevalence of chronic disorders and subsequent surgical interventions are boosting the usage of these products thus contributing toward substantial market growth.

Medical-Lifting-Sling

Home healthcare has emerged as an important area where treatment cost is much lower compared to in traditional healthcare settings. In addition, long term care and post operative recovery can be efficiently achieved in these settings. Hence, in the developed as well as developing regions home healthcare services are growing swiftly resulting in the considerable growth of this vertical.

Browse Research Report On Medical Lifting Slings Market :
www.grandviewresearch.com/industry-analysis/medical-lifting-sling-market

Further Key Findings From the Study Suggest:

  • Nylon-based medical lifting slings segment held a commanding share in 2015 and is anticipated to grow at a lucrative rate. This can be attributed to their durability and resistance to the infections.
  • Patient transfer is the primary application of these products, which held a dominating share in 2015. Universal slings, which have multiple utility, are also expected to gain a substantial share over the forecast period.
  • Reusable lifting slings were the most used products in 2015. However, with the rising incidence of infections and hygiene issues, disposable products are used to a greater extent and are expected to exhibit healthy growth over the forecast period.
  • Hospitals use these products to a large extent, as they purchase in bulk and they have a greater patient pool. This makes hospitals the largest end-user of medical lifting slings.
  • On the other hand, with the growing awareness and streamlined policies for home healthcare services, the usage of these services is surging. As a result, the growing home healthcare vertical is anticipated to increase the usage of medical lifting slings, thus affecting the market positively.
  • Europe dominated the global medical lifting slings vertical in 2015. Larger pool of geriatric patients, rising research funding in medical devices, and steadily increasing awareness amongst patients are the key growth governing factors for this region.
  • Asia Pacific is projected to witness remunerative growth in the coming eight years. Policy reforms, increasing disposable income, and economic developments are anticipated to foster the usage of advanced treatment options, and consequently engender a high demand for medical lifting slings.
  • Some of the key players in this vertical are Getinge Group (ArjoHuntleigh), Invacare Corporation, Hill-Rom, Joerns Healthcare LLC, Argo Medical, Inc., Prism Medical, DJO Global, V.Guldmann A/S, Spectra Care Group, and Drive Medical. Strategic initiatives undertaken by these market players include new product development, distribution enhancement, collaborations, mergers, and acquisitions.

View more reports of this category by Grand View Research at
www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the medical lifting sling market on the basis of product, application, usage, end use, and region:

Product Outlook (Revenue, USD Million, 2013 – 2024)

  • Nylon
  • Padded
  • Mesh
  • Canvas
  • Others

Application Outlook (Revenue, USD Million, 2013 – 2024)

  • Transfer
  • Universal
  • Hammock
  • Standing
  • Seating
  • Toilet
  • Bariatric
  • Others

Usage Outlook (Revenue, USD Million, 2013 – 2024)

  • Reusable
  • Disposable

End-use Outlook (Revenue, USD Million, 2013 – 2024)

  • Hospital
  • Home healthcare
  • Elderly Care
  • Other Healthcare Settings

Regional Outlook (Revenue, USD Million, 2013 – 2024)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Browse Press Release of this Report:
www.grandviewresearch.com/press-release/global-medical-lifting-sling-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Advertisements

Prefilled Syringes Market Opportunities To Reach $22.5 Billion By 2025

San Francisco, 11 December 2018 – According to a report published by Grand View Research, Inc.; the global prefilled syringes market is expected to reach a valuation of around USD 22.5 billion by 2025. Growing efforts for reducing human errors in drug delivery and high demand for efficient and easy-to-use drug delivery devices among healthcare professionals can drive market over the forecast period (2014 to 2025).

Prefilled syringes are increasingly replacing traditional syringe-vial combinations as they offer patient safety and convenience in dose preparation and delivery. High prevalence of chronic diseases such as rheumatoid arthritis and diabetes is projected to propel adoption of autoinjectors and pen injectors over the forecast period. Rising development of advanced devices offering safe and continent self-injections is projected to supplement market growth in near future.

japan-prefilled-syringes-market

In addition, introduction of Bluetooth connectivity and Wi-Fi technology for effective management of patient health records is also likely to augment product demand. These syringes are supposed to be ideal for vaccines and other biotech drugs. Technological developments in biopharmaceutical industry can have positive impact on demand as these syringes help in reducing the loss of potency at the time of transportation of biopharmaceuticals in different containers.

The worldwide prefilled syringes market can be segmented on the basis of type, material, application, distribution channel, and region. As per type, the market can be classified into disposable and reusable. In 2018, disposable segment dominated the market and is likely to maintain its dominance over the forecast period due to high emphasis on patient safety. These devices help reduce contamination risks, which is expected to boost demand. The reusable segment is expected to grow swiftly over the study period on account of introduction of auto-injectors.

Based on material, the market for prefilled syringes can be bifurcated into glass and plastic. In 2016, the glass segment led the market due to easy to use characteristics and reduced risk at the time of injection. However, the plastic segment is anticipated to acquire larger revenue in later phase of forecast period due to development of biocompatible materials, such as Polypropylene (PP) and crystal-clear polymer.

Browse Research Report On Prefilled Syringes Market :
www.grandviewresearch.com/industry-analysis/pre-filled-syringes-market

On the basis of application, the market can be divided into anaphylaxis, diabetes, rheumatoid arthritis, and others. In 2016, diabetes held for the larger market share due to increasing demand for effective and safer insulin delivery devices. Based on distribution channel, the market can be split into hospitals, mail order pharmacies, and ambulatory surgery centers.

Geographically, the market can be divided into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. In 2015, Europe dominated the market on account of high adoption of prefilled syringes owing to patient safety concerns. Presence of prominent players is likely to drive the market in the forthcoming years. The European Board of Anesthesiology recommends use of these syringes for anesthesia. Thus, rising number of surgical procedures and faster product approvals by various regularity bodies are expected to boost regional market.

North America is likely to exhibit rapid growth over the forecast period due to rapid adoption of these syringes. Asia Pacific is expected to display lucrative CAGR over the projected period. This growth can be attributed to rapid development in emerging countries like China and India. Presence of untapped opportunities in these counties is expected to further drive regional growth. In addition, existence of large patient base and high prevalence of chronic diseases are likely to further propel regional market growth in near future.

Key companies operating in the prefilled syringes market include Nipro Corporation, Owen Mumford Ltd, Unilife Corporation, Haselmeier AG, and Becton, Dickinson and Company. Major companies are focusing on increasing their manufacturing capacity and developing technologically advanced products. Increasing demand is likely to attract new participants to provide contract service for these syringes. New entrants are also concentrating on development of better products with latest technologies. All these factors are expected to boost business opportunities for the market participants in near future.

View more reports of this category by Grand View Research at
www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global prefilled syringes market on the basis of type, material, application, distribution channel, and region:

Prefilled Syringes Type Outlook (Revenue, USD Million, 2014 – 2025)

  • Disposable
  • Reusable

Prefilled Syringes Material Outlook (Revenue, USD Million, 2014 – 2025)

  • Glass
  • Plastic

Prefilled Syringes Application Outlook (Revenue, USD Million, 2014 – 2025)

  • Anaphylaxis
  • Rheumatoid Arthritis
  • Diabetes
  • Others
    • Vaccines and Other Biotech Drugs

Prefilled Syringes Distribution Channel Outlook (Revenue, USD Million, 2014 – 2025)

  • Hospitals
  • Mail Order Pharmacies
  • Ambulatory Surgery Centers

Prefilled Syringes Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
  • Asia Pacific
    • Japan
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Browse Press Release of this Report:
www.grandviewresearch.com/industry-analysis/pre-filled-syringes-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

Pharmaceutical Robots Market Size To Reach $430.0 Million By 2025 | Key Industry participants ABB Ltd., Yaskawa Electric Corporation

San Francisco, 11 December 2018 – The global pharmaceutical robots market is anticipated to reach USD 430.0 million by 2025, according to a new report by Grand View Research, Inc. This growth can be attributed to the flourishing pharmaceutical industry.

The pharmaceutical industry is flourishing due to huge R&D investments by global players. With increasing drug discovery and clinical trials, there is growing demand for robotics. To minimize workload and maintain higher levels of accuracy, automation has become a significant part of pharmaceutical manufacturing. It increases efficiency, prevents performance of repetitive activities, and avoids human error & contamination.

Pharmaceutical Robots Market

Technological advancement is an important factor driving growth. The use of robots & automated machines in the field of pharmaceuticals is still in its nascent stage and expected to grow in the near future. The automation industry has incorporated a few new techniques such as collaborative robots and laboratory automation.

Pharmaceutical robotic machines also minimize manufacturing costs by reducing labor. These machines are 3 to 4 times faster than humans and have the capacity to work for 24 hours. Reduction in production cost is expected to raise return on investment in the long run, thus driving demand for these products in the future.

Browse Research Report On Pharmaceutical Robots Market :
www.grandviewresearch.com/industry-analysis/pharmaceutical-robots-market

Further Key Findings From the Study Suggest:

  • In 2016, traditional robots held the largest share due to their availability in different types, varied applications, and increased awareness
  • Collaborative robots are expected to witness highest growth over the forecast period owing to their ability to easily integrate with existing manufacturing environments and interact with humans
  • Picking and packaging segment dominated the market in 2016 since almost all types of robotic machines are primarily used for picking and packaging
  • Laboratory applications are anticipated to propel significant growth over the forecast period due to increasing laboratory automation and the need to reduce the risk of human contamination
  • Pharmaceutical companies were the biggest contributors to the growth of the market in 2016 owing to a growing number of new drug development and clinical trials
  • Asia Pacific dominated the market in 2016 and is also anticipated to be the biggest driver of growth due to high penetration of robotic machines in pharma companies in countries such as China and Japan
  • Some of the key players include FANUC America Corporation; Kawasaki Heavy Industries, Ltd.; ABB Ltd.; Seiko Epson Corporation; Denso Wave Inc.; Yaskawa Electric Corporation; Universal Robots A/S; and Marchesini Group S.p.A.

View more reports of this category by Grand View Research at
www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the pharmaceutical robots market on the basis of product, application, end-use, and region:

Pharmaceutical Robots Product Outlook (Revenue, USD Million, 2014 – 2025)

  • Traditional Robots
    • Articulated Robots
    • SCARA Robots
    • Delta/Parallel Robots
    • Cartesian Robots
    • Dual-Arm Robots
  • Collaborative Pharmaceutical Robots

Pharmaceutical Robots Application Outlook (Revenue, USD Million, 2014 – 2025)

  • Picking and Packaging
  • Inspection of Pharmaceutical Drugs
  • Laboratory Applications

Pharmaceutical Robots End-Use Outlook (Revenue, USD Million, 2014 – 2025)

  • Pharmaceutical Companies
  • Research Laboratories

Pharmaceutical Robots Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Browse Press Release of this Report:
www.grandviewresearch.com/press-release/global-pharmaceutical-robots-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Hemodynamic Monitoring Devices Market Size To Reach $1.4 Billion By 2024 | Key Industry participants Deltex Medical, Edward Lifesciences

San Francisco, 10 December 2018 – The global hemodynamic monitoring devices market is expected to reach USD 1.4 billion by 2024, according to a new report by Grand View Research, Inc. The increasing demand for non-invasive monitoring techniques coupled with the rising prevalence of chronic illness is expected to drive the market over the forecast period.

The hemodynamic monitoring market is influenced by new technologies such as echocardiography, thoracic electrical bio-impedance and others that maybe used to non-invasively monitor parameters such as cardiac output, arterial pressure, blood oxygen level, and central venous pressure.

North America Hemodynamic Monitoring Devices Market share, by product, 2014 – 2024 (USD Million)

hemodynamic-monitoring-devices-market

Furthermore, the rising population of critically ill patients coupled with defective healthcare facilities with drawbacks, such as understaffing, is propelling market players to develop minimal invasive hemodynamic monitoring devices that may be used in clinical and home care settings. Along with the new product development, the market is also anticipated to witness the development of technologies that help in the early diagnosis of shock and sepsis.

Furthermore, efforts by key industry players to understand critical illnesses at molecular levels leading to the development of efficient assessment products are expected to be witnessed over the forecast period. Hence, all these company strategies and the research conducted are eventually expected to promote market growth over the forecast period.

Browse Research Report On Hemodynamic Monitoring Devices Market :
www.grandviewresearch.com/industry-analysis/hemodynamic-monitoring-devices-market

Further key findings from the study suggest:

  • The disposables segment is anticipated to be the largest segment by 2024. The rising sale of hemodynamic monitoring systems and increasing applications of these systems in home care settings, hospitals, and clinics are expected to boost the segment growth.
  • The non-invasive devices segment is expected to be the fastest growing hemodynamic monitoring market. Risks that include the development of arrhythmias due to the use of pulmonary artery catheter and the development of other methodologies that measure the cardiac output, such as echocardiographs, are the vital impact rendering drivers.
  • Asia Pacific is anticipated to be the fastest growing regions and is anticipated to contribute to about 20.0% of the global revenue by 2024. The strengthening of the distribution channels by companies and the registration of products in countries, such as China, India, Australia, and others, are expected to support the growth over the forecast period. For instance, LiDCO Group, in their 2016 prelim report emphasized on its strategy of appointing new distributors for the Australian and South East Asian region.
  • Major industry players are Edward Lifesciences, LiDCO Group Plc, Deltex Medical, Philips Medical, GE Healthcare, Noninvasive Medical Technologies, Inc., Tensys Medical, Inc., Cardio-Dynamics International, and Drager Medical, Inc. As mentioned above, the new product development is expected to drive the market over the forecast period.
  • For instance, in March 2016, the LiDCO Group received the U.S. FDA approval for the LiDCO unity and launched the product in the European region. Along the same time, LiDCO also succeeded in registering itself in China to explore untapped territories and increase their global presence.

View more reports of this category by Grand View Research at
www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Hemodynamic Monitoring Devices Market on the basis of product, type, end-use and regions.

Global Hemodynamic Monitoring Devices Product Outlook (Revenue, USD Million, 2014 – 2024)

  • Monitoring systems
    • Pulmonary artery catheters
    • Cardiac output monitors
    • Others
  • Disposables
    • Probes
    • Airflow Sensors
    • Circuits
    • Others
  • Services

Global Hemodynamic Monitoring Devices Type Outlook (Revenue, USD Million, 2014 – 2024)

  • Invasive Hemodynamic Monitoring System
  • Minimally Invasive Hemodynamic Monitoring System
  • Non-invasive Hemodynamic Monitoring System

Global Hemodynamic Monitoring Devices End-use Outlook (Revenue, USD Million, 2014 – 2024)

  • Hospitals
  • Catheterization Laboratories
  • Others

Hemodynamic Monitoring Devices Market Regional Outlook (Revenue, USD Million, 2014 – 2024)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
    • Saudi Arabia

Browse Press Release of this Report:
www.grandviewresearch.com/press-release/global-hemodynamic-monitoring-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Ophthalmic Lasers Market Worth $1.6 Billion By 2025 | Key Industry Players Alcon Laboratories, Inc., Carl Zeiss Meditec AG

San Francisco, 10 December 2018 – The global ophthalmic lasers market is anticipated to reach USD 1.6 billion by 2025, according to a new report by Grand View Research, Inc. Ophthalmic disorders are rising significantly on a global level. This rise in the prevalence rate has led to high growth of ophthalmic lasers market.

According to American Academy of Ophthalmology 2014 statistics, nearly 4.2 million people in the U.S. are visually impaired. Huge number of people suffering from visual impairment are likely to heighten the demand for ophthalmic lasers in the coming years.

U.S. ophthalmic lasers market, by product, 2014 – 2025 (USD Million)

us-ophthalmic-lasers-market

Vision loss is a serious problem among people suffering from glaucoma, cataract, age-related macular degeneration (AMD), and diabetic retinopathy. This commonly occurs among the geriatric population. American Academy of Ophthalmology stated that, around 1.3 million U.S. population are blind. Hence, in order to minimize such huge rate of vision loss, there is a high need for the application of ophthalmic laser technology.

Geriatric population are the primary target for the market. Majority of the chronic ophthalmic disorders, for instance, cataract and AMD occur among this group of population. However, refractive errors are also very common among the young people. Thus, growing number of victims of chronic eye diseases has led to an expected growth of the market.

Browse Research Report On Ophthalmic Lasers Market :
www.grandviewresearch.com/industry-analysis/ophthalmic-lasers-market

Further key findings from the study suggest:

  • In 2016, femtosecond lasers dominated the market due to rising prevalence of refractive errors among both geriatric and young population
  • Amongst the application segment, refractive error corrections held the largest market share in 2016 due to large number of surgeries conducted for refractive errors
  • Cataract removal is anticipated to show lucrative growth over the forecast period owing to the rising prevalence of cataract removal surgeries among the geriatric people
  • In 2016, hospitals contributed towards the largest revenue share owing to the emergence of large number of hospitals in developing economies
  • North America dominated the market in 2016 due to rising prevalence of ophthalmic disorders in this region
  • Asia Pacific is expected to show lucrative growth over the forecast period owing to the increase in awareness levels among people in developing countries about various treatments for chronic eye disorders
  • Few major companies include Carl Zeiss Meditec AG, Abbott Medical Optics, Inc., Alcon Laboratories, Inc., Ellex Medical Lasers Limited, Lumenis, and Bausch & Lomb Incorporated.

View more reports of this category by Grand View Research at
www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the ophthalmic lasers market on the basis of product, application, end-use, and region:

Ophthalmic Lasers Product Outlook (Revenue, USD Million, 2014 – 2025)

  • Diode Lasers
  • Femtosecond Lasers
  • Excimer Lasers
  • Nd:YAG lasers
  • SLT Lasers
  • Others

Ophthalmic Lasers Application Outlook (Revenue, USD Million, 2014 – 2025)

  • Glaucoma
  • Cataract Removal
  • Refractive Error Corrections
  • Diabetic Retinopathy
  • AMD
  • Others

Ophthalmic Lasers End-use Outlook (Revenue, USD Million, 2014 – 2025)

  • Hospitals
  • Ambulatory Surgical Centers
  • Ophthalmic Clinics

Ophthalmic Lasers Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Browse Press Release of this Report:
www.grandviewresearch.com/press-release/global-ophthalmic-lasers-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Transplant Diagnostics Market Share Analysis Report By Technology (Molecular Assays, Non-Molecular Assays)

San Francisco, 6 December 2018 – The global transplant diagnostics market size is expected to reach USD 895.2 million by 2024, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 7.6% over the forecast period. Increasing number of patients suffering from chronic diseases frequently leading to organ failure is creating an upsurge in demand for transplant procedures. In addition, adoption of stem cell therapy and personalized medicine is escalating, thereby influencing demand for transplant diagnostics.

Transplant-diagnostics-market

Risks and complexities associated with organ transplants necessitate the need for improved and sophisticated diagnostic tools. Next-Generation Sequencing (NGS) technology is rapidly replacing traditional diagnostic methods, such as serological techniques employed in Human Leukocyte Antigen (HLA) typing, owing to growing demand for high-throughput diagnostic tools with enhanced accuracy.

Market growth is expected to be restrained by factors such as reimbursement controversies and ethical issues in some parts of the world. In addition, high cost of performing HLA matching using Polymerase Chain Reaction (PCR) and NGS devices is challenging the growth of the transplant diagnostics market in developing countries.

Browse Research Report On Transplant Diagnostic Market :
www.grandviewresearch.com/industry-analysis/transplant-diagnostic-market

Further key findings from the study suggest:

  • PCR-based molecular assay captured the largest share in the overall market in 2016 due to extensive adoption in HLA typing
  • The sequencing-based typing segment is anticipated to witness significant growth from 2016 to 2024. High adoption of NGS is a major factor driving segment growth
  • In 2016, the reagents and consumables segment accounted for the largest market share attributed to repeat purchase
  • North America captured the largest revenue share in 2016 and is expected to maintain its dominance throughout the forecast period due to well-established research infrastructure, increasing healthcare expenditure, high adoption of advanced diagnostic techniques, and growing R&D activities
  • Asia Pacific is expected to witness significant growth during the forecast period owing to expanding research opportunities, healthcare expenditure, medical tourism industry, and awareness regarding organ donation
  • Some major players in this market are Thermo Fisher Scientific, Inc.; Illumina, Inc.; F.Hoffmann La-Roche AG.; Abbott Laboratories, Inc.; Qiagen N.V.; Immucor Transplant Diagnostics, Inc.; Bio-Rad Laboratories, Inc.; Affymetrix, Inc.; and Omixon Ltd.

View more reports of this category by Grand View Research at
www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global transplant diagnostics market on the basis of technology, product, and region:

Transplant Diagnostics Technology Type Outlook (Revenue, USD Million, 2014 – 2024)

  • Molecular Assay
    • PCR-based Molecular Assay
    • Sequencing-based Molecular Assay
  • Non-molecular Assay
    • Serological Assay
    • Mixed Lymphocyte Culture Assay

Transplant Diagnostics Product Type Outlook (Revenue, USD Million, 2014 – 2024)

  • Reagents & Consumables
  • Instruments
  • Software and Services

Transplant Diagnostics Regional Outlook (Revenue, USD Million, 2014 – 2024)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
  • Asia Pacific
    • Japan
    • India
  • Latin America
    • Mexico
    • Brazil
  • Middle East & Africa
    • South Africa

Browse Press Release of this Report:
www.grandviewresearch.com/press-release/global-transplant-diagnostic-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Medical Disposables Market Share, Sourcing Strategy and Downstream Buyers [2015 – 2024]

San Francisco, 5 December 2018 – The global medical disposables market is expected to reach USD 329.9 billion by 2024, according to the study performed by Grand View Research, Inc. Key factors driving the market expansion include the growing awareness regarding benefits of infection control, which majorly include enhanced quality of life and minimized related healthcare expenditure.

In addition, propelling factors of this sector comprise constantly rising hospital visits, surgeries, and the growing need for healthcare assistance owing to the escalating geriatric population prone to developing chronic diseases and injuries. Furthermore, the emergence of this sector is attributed to the increased focus toward the use of single-use disposable products to prevent cross-contamination and infection in healthcare settings.

Medical Disposables Market

These products offer a range of advantages to the healthcare institutions such as reducing sterilization and disinfection costs. Thus, most of the healthcare professionals and individual patients are turning toward disposable medical supplies to meet the infection control requirements.

Drug delivery products captured the largest revenue share in 2015. The segment is also expected to foresee the fastest growth rate due to the increasing use of prefilled syringes, needles, and transdermal patches by various hospitals and clinics.

The plastic resin segment accounted for the largest share in 2015 due to their wide availability and application in the healthcare sector. However, nonwoven material is forecasted to grow at the fastest CAGR owing to factors such as their low weight, affordable cost, and easy recycling methods. Nonwoven fabric is the material of choice for a number of applications such as wound care management, incontinence management, and surgeries due to the highly absorbent and liquid repellent nature of this material, among other properties.

Browse Research Report On Medical Disposables Market :
www.grandviewresearch.com/industry-analysis/medical-disposables-market

Further Key Findings from the Study Suggest:

  • In 2015, the drug delivery product segment captured the largest revenue share. The increasing application of various drug delivery products for sustained-release drug therapies is mainly contributing to the largest share of the segment globally.
  • In addition, rising demand for minimally invasive surgeries is spurring the demand for needles and drug delivery devices, which is resulting in the high revenue generation of the segment
  • With the introduction of advanced technology and growing demand for accurate diagnostic methods, the diagnostic and laboratory disposables segment is expected to show the second fastest growth during the forecast period
  • North America region dominated the overall market by capturing over 35.0% share in 2015. This region is anticipated to remain dominant throughout the forecast period.
  • Some of the factors having a significant impact on the regional market growth are government initiatives, high per capita income, large patient pool, and the presence of a large number of major players in the region
  • Growing economies and government-led initiatives are expected to drive the growth of the medical disposables sector in the Asia Pacific region. The segment is expected to witness a lucrative CAGR of over 7% during the forecast period.
  • Some of the major players in the consolidated market are 3M, Johnson & Johnson Services, Inc., Abbott, Becton, Dickinson & Company, Medtronic, B. Braun Melsungen AG, Bayer AG, Smith and Nephew, Medline Industries, Inc., and Cardinal Health

View more reports of this category by Grand View Research at
www.grandviewresearch.com/press-release/global-medical-disposables-market

Grand View Research has segmented the medical disposables market by product, raw material, end use, and region:

Type Outlook (Market revenue in USD Million, 2014 – 2024)

  • Wound Management Products
  • Drug Delivery Products
  • Diagnostic and Laboratory Disposables
  • Dialysis Disposables
  • Incontinence Products
  • Respiratory Supplies
  • Sterilization Supplies
  • Nonwoven Disposables
  • Others

Raw Material Outlook (Market revenue in USD Million, 2014 – 2024)

  • Plastic Resins
  • Nonwoven Material
  • Rubber
  • Paper and Paperboard
  • Metals
  • Glass
  • Others

End Use Outlook (Market revenue in USD Million, 2014 – 2024)

  • Hospitals
  • Home Healthcare
  • Outpatient/Primary care Facilities
  • Others

Regional Outlook (Market Revenue in USD Million, 2014 – 2024)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa (MEA)
    • South Africa

Browse Press Release of this Report:
www.grandviewresearch.com/press-release/global-medical-disposables-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

For More Information: www.grandviewresearch.com